- Home
- KLIC vs CNTA Comparison
KLIC vs CNTA Comparison
Compare KLIC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLIC
- CNTA
- Stock Information
- Founded
- KLIC 1951
- CNTA 2020
- Country
- KLIC United States
- CNTA United Kingdom
- Employees
- KLIC N/A
- CNTA N/A
- Industry
- KLIC Semiconductors
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- KLIC Technology
- CNTA Health Care
- Exchange
- KLIC Nasdaq
- CNTA Nasdaq
- Market Cap
- KLIC 2.0B
- CNTA 2.3B
- IPO Year
- KLIC N/A
- CNTA 2021
- Fundamental
- Price
- KLIC $35.79
- CNTA $28.38
- Analyst Decision
- KLIC Buy
- CNTA Strong Buy
- Analyst Count
- KLIC 4
- CNTA 9
- Target Price
- KLIC $45.00
- CNTA $34.13
- AVG Volume (30 Days)
- KLIC 368.0K
- CNTA 2.1M
- Earning Date
- KLIC 11-19-2025
- CNTA 11-05-2025
- Dividend Yield
- KLIC 2.29%
- CNTA N/A
- EPS Growth
- KLIC N/A
- CNTA N/A
- EPS
- KLIC 0.11
- CNTA N/A
- Revenue
- KLIC $657,842,000.00
- CNTA $15,000,000.00
- Revenue This Year
- KLIC N/A
- CNTA N/A
- Revenue Next Year
- KLIC $18.61
- CNTA N/A
- P/E Ratio
- KLIC $325.32
- CNTA N/A
- Revenue Growth
- KLIC N/A
- CNTA 118.88
- 52 Week Low
- KLIC $26.63
- CNTA $9.60
- 52 Week High
- KLIC $52.08
- CNTA $29.29
- Technical
- Relative Strength Index (RSI)
- KLIC 34.59
- CNTA 70.01
- Support Level
- KLIC $38.32
- CNTA $21.14
- Resistance Level
- KLIC $39.41
- CNTA $29.29
- Average True Range (ATR)
- KLIC 1.13
- CNTA 2.17
- MACD
- KLIC -0.41
- CNTA 0.46
- Stochastic Oscillator
- KLIC 13.07
- CNTA 93.38
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.